metformin has been researched along with Iron Overload in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Iron Overload: An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. (From Churchill's Illustrated Medical Dictionary, 1989)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luque-Ramírez, M | 1 |
| Álvarez-Blasco, F | 1 |
| Alpañés, M | 1 |
| Escobar-Morreale, HF | 1 |
1 trial available for metformin and Iron Overload
| Article | Year |
|---|---|
Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Anthropometry; Antimicrobial Cationic Peptides; Case-Control Studies; F | 2011 |